Univariate analysis | Model 1c | Model 2d | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
N (%) | ORa | 95 % CIb | P | ORa | 95 % CIb | P | ORa | 95 % CIb | P | |
Age (years) | 1.58 | 1.39–1.79 | ** | 1.53 | 1.35–1.73 | ** | 1.46 | 1.28–1.68 | ** | |
Anthropometric measurements | ||||||||||
Body mass index (BMI) | ||||||||||
C1 < 25.0 | 2107 (89.1) | |||||||||
25.0 ≤ C2 < 27.5 | 150 (6.3) | 1.27 | 0.75–2.15 | 1.23 | 0.77–1.96 | |||||
27.5 ≤ C3 < 30.0 | 58 (2.5) | 2.32 | 1.18–4.55 | * | 2.05 | 1.07–3.92 | * | |||
30.0 ≤ C4 | 50 (2.1) | 2.80 | 1.41–5.55 | ** | 2.84 | 1.50–5.40 | ** | |||
Waist circumference (cm) | ||||||||||
C1 < 85 | 1864 (78.8) | |||||||||
85 ≤ C2 < 90 | 253 (10.7) | 1.45 | 1.19–1.75 | ** | 1.28 | 0.85–1.95 | ||||
90 ≤ C3 < 95 | 149 (6.3) | 1.71 | 1.37–2.104 | ** | 1.44 | 0.87–2.39 | ||||
95 ≤ C4 | 99 (4.2) | 2.61 | 2.10–3.25 | ** | 2.32 | 1.35–4.00 | ** | |||
Atherosclerotic complications | ||||||||||
Cardiovascular disease (present) | 10 (0.4) | 9.37 | 2.69–32.63 | ** | 2.30 | 0.78–6.77 | 7.02 | 1.94–25.40 | * | |
Cerebrovascular disease (present) | 6 (0.3) | 18.69 | 3.41–102.62 | ** | 9.19 | 1.52–55.62 | * | 8.11 | 1.30–50.72 | * |
Medical history | ||||||||||
Antihypertensive drug use (yes) | 135 (5.7) | 2.60 | 1.67–4.04 | ** | 1.15 | 0.71–1.85 | 1.32 | 0.79–2.19 | ||
Antidiabetic drug use (yes) | 13 (0.5) | 2.78 | 0.76–10.18 | 0.68 | 0.15–3.21 | 1.17 | 0.24–5.63 | |||
Antidyslipidemic drug use (yes) | 119 (5.0) | 2.07 | 1.26–3.38 | ** | 1.10 | 0.66–1.84 | 0.89 | 0.50–1.60 | ||
Healthy lifestyle characteristics | ||||||||||
Smoking behavior (non–current smoker) | 2100 (88.8) | 1.22 | 0.73–2.05 | 1.13 | 0.71–1.80 | 0.99 | 0.60–1.97 |